Member Info for E_AL

True

"the Group expects 2019 full year net production to average c.87,000 bopd. The Group also expects to deliver free cash flow of c.$350 million, has liquidity headroom in excess of $1 billion and no near-term debt maturities."

Anyone listening to the conference call? Any new details Re today's RNS

hasiba, hope you'll make your mtfb loss here :)

L2 looks much better now

Anyone listening to the conference?

It must show some recovery from here , RSI is around 10% (extremely oversold)

for at "least" 30-50% recovery from here in the VERY short term ;)

"@Carrefour: I think this share is currently price right at the moment (2.5p)"

Well, I dont think the board of directors and the US investors agree with you mate:

3 Oct : Stephen Stamp, Chief Financial Officer and a Director of the Company, has purchased 250,000 ordinary shares at a price of 5.5 pence per Share. Following the purchase, Mr Stamp's holding in the Company is 450,000 Shares, representing 0.11 per cent. of the Company's issued share capital.

4 Oct : Stephen Stamp, Chief Financial Officer and a Director of the Company, has purchased 100,000 ordinary shares at a price of 5.89 pence per Share. Following the purchase, Mr Stamp's holding in the Company is 550,000 Shares, representing 0.13 per cent. of the Company's issued share capital.

7 Oct : Stephen Stamp, Chief Financial Officer and a Director of the Company, has purchased 450,000 ordinary shares at a price of 6.75 pence per Share. Following the purchase, Mr Stamp's holding in the Company is 1,000,000 Shares, representing 0.24 per cent. of the Company's issued share capital.

2 Oct : Midatech announced that an award has been made under the 2014 Midatech Pharma plc Enterprise Management Incentive Scheme to Stephen Stamp, Chief Financial Officer and a Director of the Company. The award consists of 1,000,000 share options over the Company's ordinary shares having a nominal value of 0.005 pence each (the "Options") with an exercise price of 5.25 pence per share.

28 Oct : Midatech announced the closing of its previously announced registered direct offering of 3,000,000 of its American Depositary Shares ("ADSs") (each ADS representing 20 of the Company's ordinary shares (the "New Ordinary Shares")) at a purchase price of US$1.00 per ADS (equivalent to 3.9 pence per share.

The Company issued to the Investor unregistered warrants to purchase up to 3,000,000 ADSs ("Warrant ADSs"). The warrants have an exercise price of US$1.25 per ADS (equivalent to 4.8 pence per New Ordinary Share) .

***Institutional Investors wont buy shares in a company to make loss or to break even. BOD are not obliged to buy shares in their companies unless they wont to.

RSI for MTPH & MTP (Nasdaq listing) currently in the heavily oversold area.

I am a value trader not a long tern investor & I am not interested in holding a position in any company for long term. I very much like what I see here so far and it gives me comfort to know that the company already passed EU and the Spanish government due diligence to access millions of Euros so no ponzi scheme here.

Midatech is oversold on TA charts & CFO felt comfortable to pay 110%, 120% & 135.6% the current sp two months ago to buy nice chunks of shares, his warrants @ 11% the current sp & US ii paid 92% the current sp.

I am happy to buy at this level for 30-50% recovery from here :)

Carrefour,
As the company mentioned in the RNS :” is pleased to announce that it has received confirmation of a €2.6 million EU grant ” ..... so I really can’t see why the EU would send them a grant confirmation then change their mind for whatever reason. They also said “ The funds are subject to finalisation of the grant agreement currently being prepared with the EU “ so all sound positive really & they should receive the grant as soon as the paperwork is done.

Anyway, on the 28th of Oct the company received US$3.0m from directing offering : “Midatech intends to use the proceeds from the offering to fund its development programmes, including clinical trials for its product candidates, investment in capital equipment for the commercial production of its Q-Octreotide product, MTD201, for working capital and for general corporate purposes.” So there is no urgent need for the company to raise more funds.

The transactions below took place yesterday but they were cancelled & only been reported earlier this afternoon. They were part of three big sell/buy transactions made by someone to block the sp recovery after the RNS and to drop the BID. This is called "Spoofing" : Traders or MMs spoof the BID by selling large blocks of shares to drop the BID then cancel the order(s) before it executes on the exchange."

"In the U.K., the Financial Conduct Authority and the courts are authorised to fine spoofers. According to the FCA, "Abusive strategies that act to the detriment of consumers or market integrity will not be tolerated"

https://cdn.corporatefinanceinstitute.com/assets/spoofing1.png

https://www.fxcm.com/uk/insights/what-is-spoofing/

https://www.finextra.com/blogposting/13263/how-spoofing-works-amp-why-it-is-illegal

https://pdfhost.io/v/LOcyUdFL_pf2__spoofingpdf.pdf "

05-Dec-19 14:11:41 3.60 -500,000 £-18.00k
05-Dec-19 14:42:27 3.05 -500,000 £-15.25k

I spotted the market manipulation yesterday :

"As for the share price reaction to the news, I think a big shareholder put a cap on the share price recovery when he offloaded 3 blocks of 500k:

05-Dec-19 14:11:41 3.60 500,000 18.00k
05-Dec-19 14:14:44 3.50 500,000 17.50k
05-Dec-19 14:14:44 3.50 500,000 17.50k

He bought them back 30 minutes later after he made £8.25k

05-Dec-19 14:42:27 3.05 500,000 Buy* 15.25k
05-Dec-19 14:43:37 3.05 500,000 Buy* 15.25k
05-Dec-19 14:43:37 3.05 500,000 Buy* 15.25k"

.......... Midatech IR should do something about this!

The next expected news should confirm the route of injection for the MTD201 pivotal study. If the subcutaneous route is viable, then this will further differentiate the MTD201 from Sandostatin LAR (SLAR), which can only be administered by deep intramuscular injection by a trained health care provider. The last cohort of subjects will have received their injections by 11th October. The sampling period is 63 days. All the data should have been collected by 13th December. The RNS will come sometime after that.

We are also due an update on the progress of MTX110 for DIPG. The principal investigator on the study, Dr Sabine Mueller, has so far described the safety profile as excellent. The primary outcome measure is safety and the secondary one is overall survival at 12 months:

https://clinicaltrials.gov/ct2/show/NCT03566199

A child diagnosed with DIPG today faces the same prognosis as a child diagnosed 40 years ago. What Midatech and collaborators are attempting here is to be commended.

True dvharrison and it will soon, MPTH is currently heavily oversold on TA Charts due to (imo) ii cashing out. the early morning drop was a resonance to the drop on Nasdaq yesterday although no meaningful volumes were sold here this morning. It hit the Pivot Point 1st Support Point of 2.22 and bounced back up. If the seller is done (cant see any meaningful selling so far) then we will have nice recovery from these levels very soon. BOD paid double the current sp two months ago to top up .. As for the warrants : ["Midatech backer (US institutional investor) will receive warrants for US$1.25 each, or 4.9p per UK share "]

MTPH Technical levels:

Pivot Point 2nd Level Resistance 4.520
Pivot Point 1st Resistance Point 3.635
14 Day RSI at 30% 2.923
14 Day RSI at 20% 2.766
Pivot Point Support Point 2.220

I just saw the following on Stocktwits which is a US social media platform designed for sharing ideas between investors and traders.

Someone on there emailed Tim Metcalfe (Investor Relations at Midatech Pharma) in regards to the share price reaction to the RNS and this was the respond received:

" Hi Jeff

Don’t worry, I share your frustrations! As well as being an adviser to the company, I am also a shareholder. The stock was up 45% in London in the hour after the announcement went out, an appropriate response in my view, only to close only 3% up following the Nasdaq trading and its obviously gone down further since London close.

We live in interesting times and I unfortunately see on numerous occasions here where good news creates liquidity and the sellers take advantage, ultimately pushing the price down.

This was very good news today and I will be looking in detail at what’s happened in the market and what, if anything, the company can do to address the issues.

All I can do is thank you for your support and patience.

Best regards

Tim"

Screenshot : https://i.imgur.com/MPpNsq5.png

Smashing news, impressive pipeline progress achieved so far and funding doesnt seems to be a problem. Back in September the company managed to get 6.6m Euro funding from the Spanish government [The company is pleased to announce that it has received funding of €6.6m (the "Loan") under the Spanish Government Reindustrialisation ("Reindus") programme to support the Company's manufacturing facility in Bilbao, Spain. This brings the total public financing available for this project to up to €8.5m, including previous grant and loan amounts recently approved by the Basque regional government.] & earlier today it secured $3m from US institutional investor and now 2.6m EU Grant for further clinical development of MTX110.

As for the share price reaction to the news , I think a big shareholder put a cap on the share price recovery when he offloaded 3 blocks of 500k:

05-Dec-19 14:11:41 3.60 500,000 18.00k
05-Dec-19 14:14:44 3.50 500,000 17.50k
05-Dec-19 14:14:44 3.50 500,000 17.50k

He bought them back 30 minutes later after he made £8.25k

05-Dec-19 14:42:27 3.05 500,000 Buy* 15.25k
05-Dec-19 14:43:37 3.05 500,000 Buy* 15.25k
05-Dec-19 14:43:37 3.05 500,000 Buy* 15.25k

The RNS was released abit late in the afternoon so I think the news will sink in this evening & we'll see a nice bounce back above 3p tomorrow morning GLA

Some holders who were waiting for a while to cash out just sold, the rns was quite impressive so I'd expect more people to buy when the news circulates ;)

bunsenburner123, the drop was with no news - well, profit takers selling .......

Some on loading up in bulk today, are they yours 1onic? ha

13:21:10 1.57 1,273,506 £19.99k
13:21:10 1.57 1,273,506 £19.99k

Nice chunking buys in the past hour, an overall of 3.88M shares were bought worth £58,228

Nice support on the BID since the morning, the sp should climb back up from here

Mate, noting is guaranteed in the stock market lol

Watch the presentation and it will all make sense, the Ethiopia government & financial institutions there committed 58m only for startup & they are expecting Kefi to be the largest single gold export generator for the country.

Very powerful & informative presentation! My favourite part was about mcap correcting itself in the coming weeks ;)